Immunic | VTL - Current Assets


Immunic reported $22.87M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
BioMarin Pharmaceutical USD 4.61B 651.58M Mar/2026
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Enanta Pharmaceuticals USD 198.68M 5.65M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 22.87M 16.4M Dec/2025
Insmed USD 1.79B 137.6M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Quidel USD 1.38B 70.3M Mar/2026
Ultragenyx Pharmaceutical USD 657M 294M Mar/2026
United Therapeutics USD 2.87B 830.5M Mar/2026
Xoma USD 110.71M 5.78M Sep/2025